I am Ana Bouchet, co-founder of Lifesome Therapeutics. I am an international expert in nanoparticle formulation, lipid biophysics and encapsulation processes. At Lifesome, I manage the production of the first antitumoral lipid nanoparticle in the market.
Lifesome Therapeutics S.L. is a spanish company who produces the first "smart lipid nanoparticles" in the market. Whereas other lipid nanoparticles are passive carriers, our nanoparticles have intrinsic biologic activity which enhances the antitumoral and antibiotic potential of encapsulated drugs. By doing so, we provide our clients with strong formulations that ease their progress from the lab bench to successful preclinical trials.
Dr Ana Bouchet investigated the lipid-associated dysregulation of ion channels in cancer and metastasis development at the University of Tours (France), funded by the Prestige Marie Curie Fellowship Program. She pursued Innovation Managing studies at IESE Business School (Madrid, Spain) and in 2021 she led Lifesome Therapeutics’ acceleration program (CATAPULL).
Whereas other lipid nanoparticles are passive carriers, our nanoparticles have intrinsic biologic activity which enhances the antitumoral potential of encapsulated drugs. Talk to us and we will make your drugs succeed during preclinical validation!